On-line liquid chromatography-accurate radioisotope counting coupled with a radioactivity detector and mass spectrometer for metabolite identification in drug discovery and development

被引:47
作者
Nassar, AEF
Bjorge, SM
Lee, DY
机构
[1] Bayer Corp, Dept Pharmacokinet & Drug Metab, West Haven, CT 06516 USA
[2] AIM Res Co, Newark, DE 19711 USA
关键词
D O I
10.1021/ac025934f
中图分类号
O65 [分析化学];
学科分类号
070302 [分析化学]; 081704 [应用化学];
摘要
A novel detection method combining on-line liquid chromatography-accurate radioisotope counting (LC-ARC, advanced stop flow controller) coupled with a radioactivity detector and mass spectrometer has been developed. One of the major benefits of this method is that this system enhances the sensitivity of radioisotope measurement for metabolite identification in drug metabolism studies. Another advantage to this system is the easy interface with the mass spectrometer, which allows acquisition of mass spectrometric data on-fine. For purposes of evaluating this system, in vitro microsomal incubations with [H-3]propranolol were conducted. On-line separation and identification of [H-3]propranolol metabolites was achieved without intensive sample preparation, concentration, or fraction collection. Mass spectrometric analysis showed the presence of propranolol major metabolites formed by hydroxylation, correlating with previously published results. Further evaluations of this system also were conducted using two C-14 compounds, which are herein labeled X and Y. As our results show, C-14 peaks were detected down to 6 cpm, which is similar to20 times more sensitive than commercially available flow through radioactivity detectors. The overall results suggest that the combination of LC-ARC with radioactivity detection and mass spectrometry has great potential as a powerful tool for improving the sensitivity of radioisotope measurement in metabolite identification studies during drug discovery and development.
引用
收藏
页码:785 / 790
页数:6
相关论文
共 30 条
[1]
Abramson FP, 1996, DRUG METAB DISPOS, V24, P697
[2]
CRIMS - CHEMICAL-REACTION INTERFACE MASS-SPECTROMETRY [J].
ABRAMSON, FP .
MASS SPECTROMETRY REVIEWS, 1994, 13 (04) :341-356
[3]
BAI SA, 1984, DRUG METAB DISPOS, V12, P749
[4]
BAILLIE TA, 1981, PHARMACOL REV, V33, P81
[5]
Use of a microplate scintillation counter as a radioactivity detector for miniaturized separation techniques in drug metabolism [J].
Boemsen, KO ;
Floeckher, JM ;
Bruin, GJM .
ANALYTICAL CHEMISTRY, 2000, 72 (16) :3956-3959
[6]
STABLE ISOTOPES IN PHARMACOLOGY STUDIES - PRESENT AND FUTURE [J].
BROWNE, TR .
JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (06) :485-489
[7]
HPLC-accelerator MS measurement of atrazine metabolites in human urine after dermal exposure [J].
Buchholz, BA ;
Fultz, E ;
Haack, KW ;
Vogel, JS ;
Gilman, SD ;
Gee, SJ ;
Hammock, BD ;
Hui, XY ;
Wester, RC ;
Maibach, HI .
ANALYTICAL CHEMISTRY, 1999, 71 (16) :3519-3525
[8]
SELECTIVE DETECTION OF C-13, N-15, AND DEUTERIUM LABELED METABOLITES BY CAPILLARY GAS-CHROMATOGRAPHY CHEMICAL-REACTION INTERFACE MASS-SPECTROMETRY [J].
CHACE, DH ;
ABRAMSON, FP .
ANALYTICAL CHEMISTRY, 1989, 61 (24) :2724-2730
[10]
Attomole detection of 3H in biological samples using accelerator mass spectrometry:: Application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry [J].
Dingley, KH ;
Roberts, ML ;
Velsko, CA ;
Turteltaub, KW .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (10) :1217-1222